Deferred Tax Assets, Valuation Allowance of BIOGEN INC. from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
BIOGEN INC. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • BIOGEN INC. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $832,200,000, a 18% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

BIOGEN INC. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $832,200,000 -$181,500,000 -18% 31 Dec 2025 10-K 06 Feb 2026 2025 FY
Q4 2024 $1,013,700,000 -$265,000,000 -21% 31 Dec 2024 10-K 06 Feb 2026 2025 FY
Q4 2023 $1,278,700,000 -$724,600,000 -36% 31 Dec 2023 10-K 12 Feb 2025 2024 FY
Q3 2023 $85,000,000 $0 0% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 $85,000,000 $0 0% 30 Jun 2023 10-Q 25 Jul 2023 2023 Q2
Q1 2023 $85,000,000 $0 0% 31 Mar 2023 10-K 14 Feb 2024 2023 FY
Q4 2022 $2,003,300,000 +$42,000,000 +2.1% 31 Dec 2022 10-K 14 Feb 2024 2023 FY
Q3 2022 $85,000,000 30 Sep 2022 10-Q 25 Oct 2022 2022 Q3
Q2 2022 $85,000,000 -$290,000,000 -77% 30 Jun 2022 10-Q 20 Jul 2022 2022 Q1
Q1 2022 $85,000,000 31 Mar 2022 10-K 12 Feb 2025 2024 FY
Q4 2021 $1,961,300,000 +$207,400,000 +12% 31 Dec 2021 10-K 15 Feb 2023 2022 FY
Q2 2021 $375,000,000 30 Jun 2021 10-Q 20 Oct 2021 2021 Q3
Q4 2020 $1,753,900,000 +$1,752,800,000 +159345% 31 Dec 2020 10-K 03 Feb 2022 2021 FY
Q4 2019 $1,100,000 -$18,900,000 -94% 31 Dec 2019 10-K 03 Feb 2021 2020 FY
Q4 2018 $20,000,000 +$3,400,000 +20% 31 Dec 2018 10-K 06 Feb 2020 2019 FY
Q4 2017 $16,600,000 +$500,000 +3.1% 31 Dec 2017 10-K 06 Feb 2019 2018 FY
Q4 2016 $16,100,000 +$2,000,000 +14% 31 Dec 2016 10-K 01 Feb 2018 2017 FY
Q4 2015 $14,100,000 +$2,600,000 +23% 31 Dec 2015 10-K 02 Feb 2017 2016 FY
Q4 2014 $11,500,000 +$10,000,000 +667% 31 Dec 2014 10-K 03 Feb 2016 2015 FY
Q4 2013 $1,500,000 -$10,800,000 -88% 31 Dec 2013 10-K 04 Feb 2015 2014 FY
Q4 2012 $12,300,000 +$1,500,000 +14% 31 Dec 2012 10-K 06 Feb 2014 2013 FY
Q4 2011 $10,800,000 $0 0% 31 Dec 2011 10-K 05 Feb 2013 2012 FY
Q4 2010 $10,800,000 31 Dec 2010 10-K 03 Feb 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.